Intrepida Bio attracts $9.5 mln

San Diego-based Intrepida Bio Inc, a newly launched drug developer, has secured $9.5 million in funding. The investors were Sofinnova Investments and Canaan.

ByIris Dorbian

22 October 2019•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Managers North America US Healthcare Briefs